Canada to supply experimental Ebola vaccine to World Health Organization

The Public Health Agency of Canada will begin shipping vials of its experimental Ebola vaccine to the World Health Organization, in Geneva, on Monday.

"This vaccine, the product of many years of scientific research and innovation, could be an important tool in curbing the outbreak," Dr. Gregory Taylor of the public health agency told the Toronto Star. "We will … work closely with the WHO to address some of the ethical and logistical issues around using this experimental vaccine in the fight against Ebola."

The Canadian-made vaccine began clinical trials in the United States in September; results are expected by December. But as an Ebola outbreak continues to ravage West Africa, the WHO may consider offering the experimental vaccine to countries most affected by the virus before then. So far, more than 4,500 people have died from the Ebola outbreak in West Africa.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up